Chapel Hill, NC, United States of America

Li-Hua Ping


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):

Title: The Innovative Contributions of Li-Hua Ping

Introduction

Li-Hua Ping is a notable inventor based in Chapel Hill, NC, who has made significant strides in the field of immunology. Her work primarily focuses on developing methods for HIV vaccination, aiming to enhance the production of protective antibodies against the virus. With a strong academic background and a commitment to research, she has contributed to the scientific community through her innovative ideas.

Latest Patents

Li-Hua Ping holds a patent for a method of inducing the production of protective anti-HIV-1 antibodies. This invention relates to an immunogen for HIV vaccination and specifically targets B cell germline and clone intermediates. By utilizing a combination of HIV envelope and non-HIV immunogens, her method aims to effectively induce the production of protective antibodies. The patent also includes compositions suitable for use in this innovative method.

Career Highlights

Throughout her career, Li-Hua Ping has worked with prestigious institutions such as Duke University and the University of North Carolina at Chapel Hill. Her dedication to research and innovation has positioned her as a key figure in the field of immunology. Her work has not only advanced scientific understanding but has also contributed to potential solutions for combating HIV.

Collaborations

Li-Hua Ping has collaborated with esteemed colleagues, including Barton F. Haynes and Hua-Xin Liao. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the impact of their research.

Conclusion

Li-Hua Ping's contributions to the field of immunology, particularly in HIV vaccination, highlight her innovative spirit and dedication to scientific advancement. Her patent and collaborations reflect her commitment to improving public health through research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…